Randomized clinical trials are based on probability. A drug, which works for 30% of the population, can be useless or even harmful in the remaining 70%. There has to be a better way. Here is a very interesting discussion from Forbes. Discussants: George Church, Stephen Bonner, Howard Jacob and Jonathan Rothberg.